Doximity (NYSE:DOCS) Upgraded at Zacks Research

Zacks Research upgraded shares of Doximity (NYSE:DOCS) from a hold rating to a strong-buy rating in a report issued on Monday morning,Zacks.com reports.

Several other research firms also recently weighed in on DOCS. The Goldman Sachs Group raised shares of Doximity from a “strong sell” rating to a “hold” rating in a research note on Friday, January 9th. Royal Bank Of Canada raised Doximity to a “moderate buy” rating in a research note on Thursday, January 8th. Wall Street Zen cut Doximity from a “buy” rating to a “hold” rating in a research note on Saturday, January 10th. Wells Fargo & Company raised Doximity from an “equal weight” rating to an “overweight” rating and set a $55.00 target price on the stock in a research report on Tuesday, January 20th. Finally, Truist Financial upgraded Doximity from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 8th. Three investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Doximity presently has a consensus rating of “Buy” and a consensus price target of $55.00.

Doximity Price Performance

NYSE:DOCS opened at $38.74 on Monday. Doximity has a twelve month low of $38.46 and a twelve month high of $85.21. The firm has a market capitalization of $7.29 billion, a PE ratio of 30.75, a P/E/G ratio of 1.81 and a beta of 1.39.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.